https://www.cancertherapyadvisor.com/home/cancer-topics/breast-cancer/dcis-endocrine-therapy-duration-tied-benefit-young-patients-reject-et/
0
0
11/11/22 at 3:55pm
Organization
Cancertherapyadvisor.com
Author
Erin Clancy
38 words
0
Comments
Two new studies shed light on the complexity of preventing subsequent breast cancer events in patients with ductal carcinoma in situ.
You are the first to view
Create an account
or login to join the discussion